Skip to main content

Table 6 Assessment of cardiovascular disease risk using various cardiovascular risk indicators

From: Investigating the interplay of smoking, cardiovascular risk factors, and overall cardiovascular disease risk: NHANES analysis 2011–2018

Exposure

Non-adjusted

OR (95%CI) P-value

Adjust I

OR (95%CI) P-value

Adjust II

OR (95%CI) P-value

WHtR10

1.59 (1.47, 1.72) < 0.0001

1.48(1.35, 1.63) < 0.0001

1.25 (1.11, 1.40) 0.0001

VAI

1.15 (1.10, 1.21) < 0.0001

1.18 (1.12, 1.25) < 0.0001

1.10 (1.03, 1.17) 0.0024

ABSI

4.81 (4.01, 5.76) < 0.0001

1.72 (1.39, 2.13) < 0.0001

1.36 (1.08, 1.73) 0.0099

CI

4.51 (3.81, 5.35) < 0.0001

2.20 (1.81, 2.68) < 0.0001

1.53 (1.22, 1.92) 0.0002

TyG

1.75 (1.55, 1.98) < 0.0001

1.53 (1.33, 1.77) < 0.0001

1.26 (1.07, 1.49) 0.0053

WBC

1.10 (1.06, 1.13) < 0.0001

1.12 (1.08, 1.17) < 0.0001

1.03 (1.00, 1.07) 0.0882

LYM

1.01 (0.98, 1.05) 0.3867

1.02 (0.98, 1.05) 0.3727

1.01 (0.98, 1.04) 0.6601

NEUT

1.19 (1.14, 1.25) < 0.0001

1.21 (1.15, 1.28) < 0.0001

1.09 (1.03, 1.16) 0.0028

PLR

1.00 (1.00, 1.00) 0.0444

1.00 (1.00, 1.00) 0.5565

1.00 (1.00, 1.00) 0.9849

NLR

1.38 (1.30, 1.46) < 0.0001

1.18 (1.10, 1.25) < 0.0001

1.08 (1.01, 1.16) 0.0344

MPV

1.13 (1.04, 1.23) 0.0044

1.16 (1.06, 1.27) 0.0018

1.14 (1.03, 1.26) 0.0139

  1. Non-adjusted model adjust for: None
  2. Adjust I model adjust for: Sex; Age; Race
  3. Adjust II model adjust for: Sex; Age; Race; A; ALT; AST; BUN; CR; TB; UA; Alcohol; Smoke; Anti-platelet; β-blockers; ACEI/ARB; Statin; Diuretic; Anticoagulant